ALT · Altimmune Inc
United States · RS rating 13 · As of 2026-11-03
| Price | 2.04 USD |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 18 / 19 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 5 / 26 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -28.6% |
| Sales growth Q/Q | +420.0% |
| Distance from 52-week high | +67.0% |
| Market cap (USD) | $376.0M |